Overview

Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke

Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The study is to determine the safety of human neural stem cell transplantation for the treatment of paralysis and related symptoms due to chronic motor stroke and to determine the maximum tolerated dose.
Phase:
Phase 1
Details
Lead Sponsor:
Suzhou Neuralstem Biopharmaceuticals